Chondropeptix Competitors and Similar CompaniesClear all

Chondropeptix's competitors and similar companies include Theraworx Relief, Genentech, Alembic Pharmaceuticals and Cipla.

	Chondropeptix Chondropeptix is a biotechnology company developing peptide-based drugs.	Theraworx Relief Theraworx Relief is a foam that relieves muscle cramps provided by Avadim Health.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date N/A	Founding Date N/A	Founding Date 1976	Founding Date 2010	Founding Date 1935
Type	Type Private	Type Subsidiary	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare ecommerce fitness & wellness	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Maastricht, NL HQ	Locations Asheville, US HQ Arden, US	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees N/A	Employees 7	Employees 18,077	Employees 14,858	Employees 27,764
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods ₹95.5b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit ₹195b (FY, 2026)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ₹6.7b (FY, 2026)	Net income ₹38.7b (FY, 2026)
Operating ⚠
Products	Products N/A	Products N/A	Products N/A	Products 145 (FY, 2024)	Products 1.5 k (FY, 2024)